A critical advance in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This vital tumor protector protein is frequently disabled in many forms of cancer, resulting uncontrolled https://checkbookmarks.com/story7672145/vhh-fragments-restore-the-p53-protein-new-promising-approach-for-malignant-management